Mankind Pharma to Acquire Majority Stake in Armed Cell Therapeutics
Mankind Pharma enters into an agreement to acquire a majority stake in Belgium-based Armed Cell Therapeutics, which is developing next-generation CAR-T cancer therapies.
Armed Cell Therapeutics B.V. | 16/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy